Log In
Print
BCIQ
Print
Print this Print this
 

Lysodren, mitotane

  Manage Alerts
Collapse Summary General Information
Company HRA Pharma S.A.
DescriptionIsomer of dichlorodiphenyldichloroethane and derivative of dichlorodiphenyltrichloroethane
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Cancer (unspecified)
Indication DetailsTreat functional adrenal cortical carcinoma
Regulatory Designation

EU - Orphan Drug (Treat functional adrenal cortical carcinoma)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today